Track
NON CME SESSION *This event is not part of the official ACTHIV conference as planned by the ACTHIV Program Committee
Name
Sponsored Symposium: Long-Acting Antiretrovirals for Treatment-Experienced People with HIV
Learning Objectives
Part 1 (Dr. Mills): HIV Treatment Landscape: From Daily Pills to Long-Acting Agents

Learning objectives:
Review the evolution of the HIV treatment armamentarium with a focus on the recent emergence of long-acting antiretrovirals
Assess factors associated with virologic failure and development of unsuppressed viremia
Discover the potential impact of long-acting antiretrovirals, in particular on treatment adherence in a ‘directly observed therapy’ setting

Part 2 (Dr. Beesley): Incorporating Long-Acting Antiretrovirals in Regimens for Treatment-Experienced People with HIV
Learning objectives:

Consider factors that influence selection of a new antiretroviral regimen
Explore key clinical data and unique characteristics of TROGARZO® (ibalizumab) as a long-acting antiretroviral for treatment-experienced PWH
Relate clinical outcomes of TROGARZO® to the patient experience, with a deep dive on a patient case with adherence issues
Description

Speakers:

Anthony Mills, MD - Men's Health Foundation, Los Angeles, CA

Brian Besley, DO, AAHIVS - AHF Columbus, OH

Virtual Session Link
View Session
Dial in information
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Germantown)
+1 346 248 7799 US (Houston)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)

Meeting ID: 878-1595-7853
Password: 236278